Becton, Dickinson and Co. (BDX) said Wednesday it plans to increase capacity for critical medical devices by making new investments in its manufacturing facilities in the US.
The company intends to invest more than $30 million this year to increase manufacturing capacity for IV lines at its Utah plant.
Becton, Dickinson said it installed new needle and syringe production lines at its plants in Connecticut and Nebraska as part of its 2024 investment of more than $10 million. One line is now fully operational, while additional lines are likely to start up in the coming months, the company said.
Price: 235.45, Change: -0.35, Percent Change: -0.15
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。